Trump’s positive attitude toward the legalization of cannabis in the U.S. could take the rapidly growing CBD pet industry to a whole new level

NEW YORK, Jan. 09, 2019 (GLOBE NEWSWIRE) -- News Commentary - Two more states legalized medical pot, Utah and Missouri recently, which increased the number of states to have legalized cannabis in some capacity to 32. We also saw the green light given to adult-use pot in two states Vermont and Michigan, raising the number of recreational marijuana states to 10. Two other positive signs are the U.S. Food and Drug Administration’s first cannabis-derived drug approval, and President Trump signed the Farm Bill into law, thereby legalizing hemp and hemp-based cannabidiol (CBD), the nonpsychoactive cannabinoid best known for its perceived medical benefits.

The rapid expansion of treating pets with alternative medicine made with CBD is fueling interest, desire, and conversations amongst pet parents and the veterinary community.

In 2017, sales of cannabis products marketed for pets at medical and adult-use cannabis dispensaries was nearly $7 million in California, Colorado, Oregon and Washington, according to BDS Analytics. In Colorado, sales of pet products grew 49 per cent in 2017, versus growth across all product categories at 15 per cent, it said.

Greg Shoenfeld, vice president of operations for BDS Analytics, based in Colorado said: "Being able to develop a presence with the pet loving consumer could be a point of strength."

According to CBD has a whole host of possible uses when it comes to pets. Some of them include helping with such ailments as:

  • Allergies
  • Anxiety
  • Appetite
  • Arthritis
  • Phobias
  • Skin Problems

According to the site, many veterinarians have found that CBD can help older pets with joint pain. In the words of, “[CBD is] useful in treating acute ailments like sprains and strains, torn ligaments, bone breaks, and even during post-operative care to reduce swelling, pain, and stiffness.”

The Cannabis sector has shown exciting promise in terms of opportunities for investors looking to the space.

If you're looking for ways to gain exposure to the U.S. cannabis industry, EnviroTechnologies International, Inc. (OTC: ETII), a publicly traded company based in Utah who already has one foot in the CBD pet industry, could be the right choice for both short and long term investors.

In a recent press release, the company reported that its subsidiary, CBD Health Co., (, a company that markets and sells high quality and proprietary hemp-based, natural CBD health products, is progressing in its hemp-based pet supplement products development.

"Much has been written lately about CBD products and the numerous applications for humans and pets, which has raised consciousness of CBD’s therapeutic value. Our CBD products are all cannabidiol-based, which means they are not psychoactive and are safe for pets,” said Joe De Leon, CBD’s President. “When your pet gets sick, you want the best treatment available and the products we are developing will offer better, more effective and safer medicinal options for pets than traditional pet health products.”

“Pet owners are committed to their pet’s health and well-being and are willing to spend money on pet health products, which make this a multi-billion dollar market, worldwide," said Gaylord Karren, ETI’s President. “We hope to introduce our CBD pet products in 2019 as we believe that our CBD pet products will be superior to those currently offered in this huge industry and will create another profitable channel for our CBD products.”

The company also confirmed today that it has commenced an audit to become a fully reporting company and transition to the QB.

“We have been transparent with our financial information but we have not, to date, committed to a formal audit, which we determined is the next logical step in our progression as a public company,” said Karren. “We expect to complete our audit by the end of first quarter 2019, which will then allow us to move to the QB and expand our options in the public marketplace.”

Investors should consider taking full advantage of the pullback in EnviroTechnologies International, Inc. (OTC:ETII) Shares.

For commentary inquiries, please contact:

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and OI undertakes no obligation to update such statements.

You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information contained in our disseminated emails does not constitute investment, legal or tax advice upon which you should rely. The purchase of high-risk securities may result in the loss of your entire investment. Advertisements received by you are not a solicitation or recommendation to buy securities of the advertised company. 

Full Disclaimer: